Molecular Partners AG

NASDAQ: MOLN · Real-Time Price · USD
3.45
-0.07 (-1.99%)
At close: Aug 15, 2025, 3:43 PM
3.53
2.27%
After-hours: Aug 15, 2025, 04:04 PM EDT

Molecular Partners Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
81.37M 63.87M 65.75M 159.13M 174.13M 186.89M 68.4M 63.24M 73.93M 87.95M 69.7M 114.94M 142.02M 71.81M 82.91M 126.57M 145.6M
Short-Term Investments
49.54M 85.56M 77.87M 93.44M 105.79M 119.58M 138.22M 154.95M 158.44M 161.2M 197.43M 170.12M 154.23M 61M 71.35M 47.7M 39.43M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a -6.18M -6.63M -7.05M -7.51M -7.48M -7.81M n/a 1K n/a n/a n/a
Receivables
3.98M 286K 3.32M 3.37M 3.18M 3.08M 1.79M 1.51M 1.74M 1.7M 1.73M 2.58M 3.47M 25.73M 5.58M 7.91M 7.03M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.02M -7.82M n/a n/a
Other Current Assets
2.07M 2.31M 2.6M 3.11M 2.87M n/a 3.52M 4.15M 3.36M n/a 4.82M 3.84M n/a n/a n/a n/a n/a
Total Current Assets
136.95M 154.28M 149.53M 165.6M 180.19M 192.46M 211.93M 223.86M 237.48M 254.75M 273.69M 291.49M 303.61M 164.19M 167.65M 198.07M 163.8M
Property-Plant & Equipment
4.12M 4.2M 4.6M 4.89M 5.25M 5.68M 5.92M 6.36M 6.77M 7.24M 7.19M 7.52M 7.95M 8.15M 8.45M 8.62M 8.94M
Goodwill & Intangibles
24K 49K 82K 122K 165K 212K 266K 277K 287K 271K 287K 291K 285K 330K 265K 297K 297K
Total Long-Term Assets
4.14M 4.25M 4.68M 5.01M 5.42M 5.89M 6.18M 6.63M 7.05M 7.51M 7.48M 7.81M 8.23M 8.48M 8.71M 8.92M 9.23M
Total Assets
141.1M 158.53M 154.21M 170.62M 185.6M 198.35M 218.12M 230.49M 244.53M 262.26M 281.16M 299.29M 311.84M 172.67M 176.36M 206.99M 173.03M
Account Payables
2.4M 679K 2.38M 2.86M 3.21M 1.33M 2.1M 2.74M 2.86M 997K 3.42M 5.55M 4.55M 4.86M 3.8M 10.51M 9.63M
Deferred Revenue
n/a n/a n/a 585K 1.91M 4.33M 4.23M 5.84M 6.46M 6.41M 7.96M 9.01M 17.94M 28.31M 25.74M 36.17M 39.56M
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -39.56M
Other Current Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
8.96M 10.79M 10.44M 11.36M 12.28M 14.42M 14.54M 15.67M 15.38M 17.25M 19.05M 23.31M 30.43M 46.87M 39.68M 57.62M 57.5M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
3.02M 4.88M 3.47M 1.85M 2.64M 5.06M 3.78M 4.38M 2.72M 2.55M 2.31M 454K 4.52M 6.74M 5.99M 7.74M 10.7M
Total Long-Term Liabilities
3.94M 6.11M 5M 3.69M 4.78M 7.51M 7.37M 8.85M 6.99M 9.84M 10.68M 10.11M 16.91M 18.51M 12.25M 14.73M 20.78M
Total Liabilities
12.9M 16.89M 15.43M 15.05M 17.06M 21.92M 21.91M 24.52M 22.37M 27.09M 29.73M 33.42M 47.34M 65.38M 51.94M 72.35M 78.28M
Total Debt
2.14M 2.44M 2.75M 3.05M 3.35M 3.65M 3.95M 4.25M 4.55M 4.85M 5.15M 5.45M 5.74M 6.04M 6.33M 6.63M 6.92M
Common Stock
4.04M 4.04M 3.67M 3.67M 3.64M 3.63M 3.63M 3.63M 3.61M 3.6M 3.6M 3.25M 3.23M 3.23M 3.23M 3.23M 2.92M
Retained Earnings
-260.88M -246.29M -232.49M -214.63M -200.5M -191.75M -170.83M -160.06M -142.53M -127.78M -110.38M -95.48M -95.32M -250.95M -232.51M -222.21M -208.47M
Comprehensive Income
n/a n/a n/a -0.00 -0.00 0.00 -0.00 -981K 0.00 -981K -0.00 -0.00 -0.00 n/a 0.00 0.00 -0.00
Shareholders Equity
128.19M 141.64M 138.78M 155.57M 168.54M 176.43M 196.21M 205.98M 222.16M 235.17M 251.43M 265.87M 264.5M 107.29M 124.43M 134.64M 94.76M
Total Investments
49.54M 85.56M 77.87M 93.44M 105.79M 119.58M 138.22M 154.95M 158.44M 161.2M 197.43M 170.12M 154.23M 61M 71.35M 47.7M 39.43M